Citizens Rates Axon Enterprise (AXON) buy, $700 Price Target

Trevor Walsh at Citizens reiterated a buy rating on the public safety technology firm, pointing to a large gap between the current price and his valuation, a 50.59% upside from the current price.

By TradeTexts Research Desk · Published Jun 25, 2026, 11:01 AM EDT · Updated Jun 29, 2026, 12:02 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Citizens rated Axon Enterprise, Inc. ($AXON) "buy" with a $700 price target on June 25, 2026.

Since the rating, $AXON is up 34.2% after 1 week, up 18.2% after 1 month and down 12.2% to date (from the $444.73 close on Jun 25, 2026).

AXON Axon Enterprise, Inc.

$390.29 -30.73% year to date

Daily close · Oct 16, 2026

Key Points

Citizens analyst Trevor Walsh reiterated a buy rating and a $700 price target for Axon Enterprise on June 25, 2026.
Citizens's $700 price target implies 50.59% upside from Axon Enterprise, Inc.'s ($AXON) current $464.83 share price.
The stock was trading at $464.83 on Thursday, which leaves a gap of more than $235 between the market price and the analyst's target.
Axon recently reported annual revenue of $3.22 billion with a 35.3% growth rate, though it trades at a high trailing P/E ratio of 173.1.

Get $AXON trade alerts by text

We text you when insiders, Congress or big funds trade $AXON. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Axon Enterprise, Inc. alert may contain errors. Disclosures

Citizens Analyst Eyes Significant Upside for Axon

Analyst Trevor Walsh from Citizens reiterated a buy rating on Axon Enterprise, Inc. (NASDAQ: AXON) on June 25, 2026. The firm kept its price target at $700.00, suggesting the stock has plenty of room to run from its current levels. This rating comes as the company continues to dominate the market for police body cameras and digital evidence management software.

On Thursday, shares of Axon were trading at $464.83. The $700.00 target from Citizens implies a price gap of roughly $235.17 per share. While the stock has traded as high as $764.02 over the last year, it has recently hovered closer to its 50-day moving average of $505.34. The current price sits just below its 200-day moving average of $489.57, making this a pivotal moment for investors watching for a potential rebound.

Broad Analyst Support for Axon Enterprise

Citizens isn't the only firm keeping a close watch on the Scottsdale-based company. On September 3, 2026, Argus Research maintained its buy rating and raised its target from $460.00 to $600.00. Earlier, on August 6, 2026, several other firms updated their outlooks following recent performance data. Barclays maintained an overweight rating and hiked its target to $688.00 from $523.00, while Piper Sandler lifted its target to $732.00 from $724.00.

Not everyone is as bullish, however. UBS maintained a neutral rating on August 6, 2026, though it did raise its price target to $600.00 from a previous $440.00. Morgan Stanley also stays positive, maintaining an overweight rating on August 6 with a target of $640.00. Overall, the group of 19 analysts covering the stock gives it a consensus buy recommendation with an average price target of $690.68.

Growth and Earnings Performance

Axon Enterprise has shown strong top-line momentum. The company generated $3.22 billion in revenue, representing a 35.3% increase over the prior year. While the business is profitable with earnings per share (EPS) of $2.41, it trades at a high trailing P/E ratio of 173.1. This suggests investors are paying a premium for its future growth potential. Looking ahead, the forward P/E ratio drops to 39.57, suggesting analysts expect earnings to catch up with the stock price over time. The company’s next earnings update is expected on November 3, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 27/100

Reported May 6, 2026

Forward outlook
4 target cuts vs 1 raises.
EPS & revenue
EPS missed estimates by 1.3%. Revenue beat estimates by 1.7%.
Profit surprise
EBITDA missed by 65 percent. Operating income missed by 69 percent.
Pre-earnings setup
Bar was high, analysts already very bullish.
Analyst signal
1 target raise, 4 target cuts.
Earnings quality
Gross margin down 1.5 points. Operating margin up 5.7 points. Positive free cash flow.

Earnings Call Summary

The quarter was the strongest ever for first quarter results, with revenue up 34 percent year over year to 807 million dollars. AI Era Plan bookings jumped 140 percent and Dedrone counter-drone business exploded up 500 percent, driven by demand across law enforcement, enterprise, and international markets. Management says they are at an inflection point where AI and connected devices are becoming essential infrastructure that customers want to deploy immediately, with nearly all large police agencies now including AI in their technology plans.

Guidance Axon expects full year revenue growth of 30 to 32 percent and raised that guidance from prior expectations. The company plans to spend about 450 million dollars on free cash flow this year and maintain 25.5 percent adjusted EBITDA margins. Management says AI adoption and counter-drone demand are accelerating faster than planned.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Public Safety Technology Leadership

Axon Enterprise is the company formerly known as Taser International. It has evolved far beyond its original stun-gun roots to become a software-heavy technology provider. Today, it sells cloud-based services like Axon Evidence to help police departments manage digital files and video. It also produces body cameras and drone technology. Because many of its customers sign long-term software contracts, the company has a steady stream of recurring revenue that investors often find attractive.

What to Watch at Axon Enterprise, Inc.

Investors should monitor the gap between the current share price and these high analyst targets. While the $700.00 target from Citizens represents a bullish outlook, the stock's high valuation relative to its current profits remains a key factor to weigh. Further filings from institutional investors and the upcoming November earnings call will provide more clarity on whether Axon can meet these high expectations. Keep in mind that analyst ratings are based on data available at a specific moment and can change as market conditions shift.

12-month forecast